Skip to content
★ Sign in to follow
Neonc Technologies Holdings, Inc. logo

Neonc Technologies Holdings, Inc. Stock: price and insider trades · United States

US·Mcap US$79.8MHealth Care

3 insiders bought €624k of shares over the last 90 days, the latest by CHEN THOMAS C, filed 15 Sept 2026.

Neonc Technologies Holdings, Inc.: what insiders have been doing

This page follows insider dealings at Neonc Technologies Holdings, Inc. as filed with SEC (Form 4), a company from the Health Care sector. The last twelve months, up to 22 October 2026, brought 33 filings signed by 7 insiders.

Both sides are active: 28 purchases worth €1.1M and 1 sale worth €15k, from 5 insiders and 1 insider respectively. Netting one side against the other leaves €1.1M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €117k, bought by Heshmatpour Amir F and made public on 14 September 2026 (0.17% of market cap). Among those who bought: 2 finance chiefs, 2 senior executives and 2 chief executives.

In all, 20 purchases were made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 15 September 2026, 54 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4.

With 33 filings in twelve months, the company is more active than the median of 24 filings across the 3,171 companies we follow on the same exchange. Since 2025, the database holds 44 purchases and 10 sales by insiders of the company. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 39,990 USD and net income of -62.1 m USD.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
84
Thresholds
n/a
Buy Volume
€1M
44 ops. · all time
Sell Volume
€3M
10 ops. · all time

Who traded when

BuySale
Amir F. Heshmatpour23 buys1 sale
Thomas C. Chen10 buys2 sales
Keithly Garnett5 buys3 sales
Delshad Jim3 buys
Chiang Ming-Fu (alan)2 sales
Walters Patrick2 sales

+2 other insiders

Since the insiders bought

  • Filed 15 Sept 2026 · 54 days ago · €17k
    -9.7%
    Entry US$2.99 · Close 16 Oct 2026 US$2.70
  • Filed 15 Sept 2026 · 54 days ago · €864
    -9.7%
    Entry US$2.99 · Close 16 Oct 2026 US$2.70
  • Filed 15 Sept 2026 · 54 days ago · €51k
    -9.7%
    Entry US$2.99 · Close 16 Oct 2026 US$2.70

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$2.77
Analyst consensus
4 analysts
1.25/5
US$13.00Target US$17.00(+514%)US$20.00
Income statement
RevenueUS$40k
EBITDA-US$59.6M-149050% margin
Net income-US$62.1M-155404.4% margin
Valuation
PER (forward)-2.5x
Balance sheet & cash
Market capUS$79.8M
Total debtUS$6.3M
Free Cash Flow-US$20.9M
Profitability & ownership
ROA-635.0%
% insiders49.8%
% institutions11.0%
Last declaration on 18 September 2026
Declarations84 total
  • ▼
    CFOExecutives
    16,809 USD38SEC
    5,000 shares@ US$3.36180.021% mcap68.6% of flowCommon StockSEC:0001213900-26-101592:0
  • ●
    OfficerExecutives
    18,900 USD26Source
    5,000 shares@ US$3.780.024% mcap100.0% of flowCommonSEC144:0001950047-26-009519
  • ▲
    CEOExecutives
    20,002 USD51SEC
    5,556 shares@ US$3.600.025% mcap6.1% of flowCommon StockSEC:0001213900-26-100266:0
    Canonical exit: 10 Dec 2026 (T+90)
  • ▲
    CEOExecutives
    19,998 USD54SEC
    5,242 shares@ US$3.8150.025% mcap6.1% of flowCommon StockSEC:0001213900-26-100266:1
    Canonical exit: 13 Dec 2026 (T+90)
  • ▲
    CFOExecutives
    1,001 USD41SEC
    257 shares@ US$3.89480.0012% mcap4.1% of flowCommon StockSEC:0001213900-26-100265:0
    Canonical exit: 13 Dec 2026 (T+90)
  • ▲
    CEO, PresidentExecutives
    59,400 USD57SEC
    15,000 shares@ US$3.960.074% mcap6.3% of flowCommon StockSEC:0001213900-26-100269:0
    Canonical exit: 13 Dec 2026 (T+90)
  • ▲
    CEO, PresidentExecutives
    115,395 USD58SEC
    35,000 shares@ US$3.2970.14% mcap12.3% of flowCommon StockSEC:0001213900-26-100269:1
    Canonical exit: 14 Dec 2026 (T+90)
  • ▲
    CEO, PresidentExecutives
    135,620 USD56SEC
    37,000 shares@ US$3.66540.17% mcap14.3% of flowCommon StockSEC:0001213900-26-099422:0
    Canonical exit: 10 Dec 2026 (T+90)
  • ▲
    CEOExecutives
    69,998 USD54SEC
    12,757 shares@ US$5.4870.072% mcap21.5% of flowCommon StockSEC:0001213900-26-092277:0
    Canonical exit: 16 Nov 2026 (T+90)
  • ▲
    Chief Scientific OfficerExecutives
    4,899 USD33SEC
    948 shares@ US$5.16771.5% of flowCommon StockSEC:0001213900-26-092276:0
    Canonical exit: 9 Jul 2026 (T+90)
  • ▲
    Chief Scientific OfficerExecutives
    48,000 USD36SEC
    10,000 shares@ US$4.8014.6% of flowCommon StockSEC:0001213900-26-092276:1
    Canonical exit: 23 Jul 2026 (T+90)
  • ▲
    CEOExecutives
    130,002 USD56SEC
    33,787 shares@ US$3.84770.13% mcap40.0% of flowCommon StockSEC:0001213900-26-091231:0
    Canonical exit: 12 Nov 2026 (T+90)
  • ▲
    CEOExecutives
    9,998 USD48SEC
    2,472 shares@ US$4.04450.010% mcap3.1% of flowCommon StockSEC:0001213900-26-091231:1
    Canonical exit: 15 Nov 2026 (T+90)
  • ▲
    CEO, PresidentExecutives
    49,860 USD53SEC
    9,000 shares@ US$5.540.051% mcap5.3% of flowCommon StockSEC:0001213900-26-091150:0
    Canonical exit: 16 Nov 2026 (T+90)
  • ▲
    CEO, PresidentExecutives
    45,460 USD39SEC
    12,000 shares@ US$3.78830.047% mcap4.8% of flowCommon StockSEC:0001213900-26-090894:0
    Canonical exit: 12 Nov 2026 (T+90)
  • ▲
    CEO, PresidentExecutives
    13,120 USD37SEC
    3,000 shares@ US$4.37330.014% mcap1.4% of flowCommon StockSEC:0001213900-26-090894:1
    Canonical exit: 15 Nov 2026 (T+90)
  • ◆
    DirectorExecutives
    0SEC
    50,000 sharesCommon StockSEC:0001829126-26-007540:0
  • ▲
    PresidentExecutives
    45,180 USD43SEC
    10,000 shares@ US$4.5180.039% mcap4.7% of flowCommon StockSEC:0001213900-26-048701:0
    Canonical exit: 27 Jul 2026 (T+90)
  • ▲
    CFOExecutives
    1,614 USD0SEC
    300 shares@ US$5.3818.4% of flowCommon StockSEC:0001213900-26-047644:0
    Canonical exit: 14 Jul 2025 (T+90)
  • ▲
    Chief Clinical OfficerExecutives
    2,440 USD30SEC
    500 shares@ US$4.880.0021% mcap24.7% of flowCommon StockSEC:0001213900-26-047648:0
    Canonical exit: 22 Jul 2026 (T+90)
  • ▲
    PresidentExecutives
    49,000 USD41SEC
    10,000 shares@ US$4.900.042% mcap5.1% of flowCommon StockSEC:0001213900-26-047218:0
    Canonical exit: 22 Jul 2026 (T+90)
  • ▲
    Chief Accounting OfficerExecutives
    1,000 USD39SEC
    200 shares@ US$5.00100.0% of flowCommon StockSEC:0001213900-26-043112:1
    Canonical exit: 8 Jul 2026 (T+90)
  • ◆
    Chief Accounting OfficerExecutives
    0SEC
    111,666 sharesCommon StockSEC:0001213900-26-043112:0
  • ▲
    PresidentExecutives
    48,950 USD29SEC
    10,000 shares@ US$4.8950.042% mcap5.1% of flowCommon StockSEC:0001213900-26-042427:0
    Canonical exit: 9 Jul 2026 (T+90)
  • ▲
    PresidentExecutives
    56,050 USD29SEC
    10,000 shares@ US$5.6055.9% of flowCommon StockSEC:0001213900-26-041899:0
    Canonical exit: 7 Jul 2026 (T+90)

25 of 84 declarations

About Neonc Technologies Holdings, Inc.

Neonc Technologies Holdings, Inc. is a NASDAQ-listed company focused on developing innovative solutions in the technology sector. It aims to enhance health outcomes through its products and services.